We have advanced by leaps and bounds in our collective fight against cancer over the last several years. Because of #ClinicalResearch, patients around the world can benefit from new treatments offering improved efficiency, less negative sides effects, and increased survivorship rates.
We are so excited to share that an amazing new trial for malignant skin and soft tissue cancers hosted here at West recently saw a 100% response rate – meaning complete disappearance of the treated tumor!
Recently featured on Action News 5‘s Cancer Watch segment is Dr. Robert Den, Chief Medical Director of Alpha Tau Medical, which is the clinical trial’s sponsor, along with Dr. Noam VanderWalde, West Radiation Oncologist and Director of Clinical Research Operations.